Market Place
Sourcing Support
AffyImmune Adds Drs Rutter And Nieva To Board Of Directors
23 Sep 2024 //
BUSINESSWIRE
AffyImmune Gets FDA RMAT Designation For AIC100 In Thyroid Cancer
23 Jul 2024 //
BUSINESSWIRE
AffyImmune Appoints Dr. Daniel Janse as Chief Executive Officer
15 Jul 2024 //
BUSINESSWIRE
Affyimmune Complete Anaplastic: Thyroid Cancer Response Confirmed
23 May 2024 //
BUSINESSWIRE
AffyImmune Announces Clinical to Support Development of AIC100 in Solid Tumors
08 Apr 2024 //
BUSINESSWIRE
AffyImmune Appoints Matt Britz as CEO & Pete Gelinas as SVP of CMC
19 Mar 2024 //
BUSINESSWIRE
AffyImmune Therapeutics to Present Poster at 2024 Annual Meeting
05 Mar 2024 //
BUSINESSWIRE
AffyImmune Therapeutics to Participate in a Fireside Chat
20 Feb 2024 //
BUSINESSWIRE
AffyImmune Therapeutics Adds Robert Forrester to Board of Directors
29 Sep 2022 //
PRNEWSWIRE
AffyImmune Therapeutics Announces Hiring of Dr. Sonal Gupta as Senior VP
25 Apr 2022 //
PRNEWSWIRE
AffyImmune snags $30M for `tune and track` platform for CAR-T
08 Oct 2021 //
FIERCEBIOTECH
AffyImmune` AIC100 Granted Fast Track Designation for Treating Thyroid Cancer
17 May 2021 //
PRNEWSWIRE
AffyImmune ` AIC100 Granted Fast Track Designation for Treating Thyroid
17 May 2021 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.